Investment Rating - The report assigns a "Buy" rating for Ryman Healthcare with a 12-month price target of NZ$4.70, while the current price is NZ$2.41 [10][27]. Core Insights - Ryman Healthcare's sales volumes and free cash flow (FCF) exceeded UBS estimates, but the FY26E sales guidance is below consensus expectations [2][7]. - The company achieved a total build rate of 950 units, slightly above UBS estimates of 937, and sold 416 new units, a 7% year-over-year increase [4][7]. - The average new unit price increased by 4% year-over-year to NZ$974k, while the average resale price rose by 1% to NZ$735k [4][7]. - Ryman Healthcare's net debt decreased to NZ$1.67 billion from NZ$2.51 billion in FY24, and the net tangible assets (NTA) per share fell to NZ$4.18 from NZ$5.01 in FY24 [4][7]. Financial Performance - Care and village fees reached NZ$571 million, a 12% increase year-over-year, surpassing UBS estimates of NZ$559 million [3]. - Deferred Management Fees were NZ$155 million, an 11% increase year-over-year, compared to UBS estimates of NZ$138 million [3]. - Operating expenses rose by 6% year-over-year to NZ$751 million, exceeding UBS estimates of NZ$700 million [3]. - The FCF for FY25 was -NZ$94 million, an improvement from -NZ$187 million in FY24, and better than UBS's estimate of -NZ$101 million [3][7]. Guidance - For FY26E, Ryman Healthcare projects total ORA sales between 1,100 and 1,300 units, significantly below UBS's estimate of 1,592 and consensus of 1,489 [6][7]. - The total build rate for FY26E is expected to be between 226 and 330 units, again below UBS's estimate of 252 and consensus of 302 [6][7]. Valuation - The price target of NZ$4.70 is based on a discounted cash flow (DCF) analysis and sum-of-the-parts (SOTP) valuation [5][14].

Core Insights - The Everhome Suites brand is experiencing strong developer interest and demand for midscale extended stay accommodations across various states, indicating a positive market trend for this segment [1][2] - The collaboration between Choice Hotels and Highside Companies is focused on launching new properties that cater to specific market needs, enhancing the brand's operational model and guest experience [2] Development Overview - Everhome Suites is expanding its footprint with several new openings and constructions in Texas, Arizona, Oregon, and Ohio, targeting strategic locations to meet diverse traveler needs [4][5][7][8] - The properties are designed to support various demographics, including military, medical, and corporate travelers, with amenities that cater to long-term stays [4][5][8] Property Details - In Texas, multiple Everhome Suites locations are set to open between February 2025 and June 2025, with properties in Bastrop, Waco, Brownsville, El Paso, and Amarillo, each strategically located near key employers and attractions [5] - The Everhome Suites in Yuma, Arizona, is scheduled to open in July 2025, focusing on military and medical travelers due to its proximity to MCAS Yuma and Yuma Regional Medical Center [4] - The Salem, Oregon location is expected to open in Q3 2026, expanding the brand's presence in the Pacific Northwest and serving local healthcare and government sectors [7] - In Ohio, a new property in Dayton is set to break ground in June 2025, positioned to attract highway travelers and military personnel due to its location near major transport routes and facilities [8] Brand Features - Everhome Suites offers apartment-style suites with fully equipped kitchens, spa-like bathrooms, and modern amenities designed for extended stays, including fitness centers and self-service marketplaces [10] - The brand emphasizes a "Closer to Home" experience, allowing guests to maintain their routines while traveling [10] Company Background - Choice Hotels International is one of the largest lodging franchisors globally, with over 7,500 hotels and a diverse portfolio of 22 brands, catering to various traveler needs [11] - Highside Companies, founded in 2019, is a real estate firm with nearly $1 billion in active projects, focusing on investment and development solutions across multiple asset classes [12]

Core Points - CareCloud, Inc. held its 2025 Annual Shareholders' Meeting on May 27, 2025, where shareholders re-elected three board members and approved executive compensation and the appointment of an accounting firm [1][2][3] - The re-elected board members include Anne Busquet, Bill Korn, and Lawrence Sharnak, all of whom have extensive experience in executive roles [2] - The shareholders approved the advisory compensation for the Company's named executive officers as disclosed in the 2025 Proxy Statement [1][7] - Rosenberg Rich Baker Berman, P.A. was appointed as the independent registered public accounting firm for the year ending December 31, 2025 [1][7] Company Overview - CareCloud is a leader in healthcare technology solutions, providing services that enhance financial and operational performance, streamline clinical workflows, and improve patient experiences [4] - The Company serves over 40,000 providers, helping them reduce administrative burdens and operating costs while improving patient care [4]

Core Points - CareCloud, Inc. held its 2025 Annual Shareholders' Meeting on May 27, 2025, where shareholders re-elected Anne Busquet, Bill Korn, and Lawrence Sharnak to the Board for another two-year term [1][2] - Shareholders approved the advisory compensation for the Company's named executive officers as disclosed in the 2025 Proxy Statement [1][7] - Rosenberg Rich Baker Berman, P.A. was appointed as the independent registered public accounting firm for the year ending December 31, 2025 [1][7] Group 1 - Anne Busquet has over 30 years of executive experience with American Express and Interactive Corp [2] - Bill Korn served as Chief Financial Officer for 10 years before retiring in October 2023 [2] - Lawrence Sharnak held various senior leadership roles at American Express for more than 30 years [2] Group 2 - CareCloud provides technology-enabled solutions aimed at improving financial and operational performance, streamlining clinical workflows, and enhancing patient experience [4] - The Company serves over 40,000 providers, helping them improve patient care while reducing administrative burdens and operating costs [4]

Investor Presentation FIRST QUARTER | FISCAL YEAR 2026 Forward Looking Statements This presentation includes express or implied statements that are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or our future financial or operational performance and may contain projections of our future results o ...

Summary of ON24 (ONTF) Update / Briefing May 28, 2025 Industry Overview - The report focuses on the life sciences industry, particularly digital engagement benchmarks for healthcare practitioners (HCPs) including pharmaceutical and medical device companies [6][8]. Key Insights and Trends 1. **Increased Engagement**: - The average number of attendees for webinars increased by 22% year-over-year to approximately 211 [8]. - Total audience engagement per webinar for life sciences companies saw a 34% increase, indicating that audiences are more active and engaged than ever before [23]. - There was a 28% increase in certifications delivered during webinars, showcasing a shift towards real-time testing and certification [24]. 2. **Webinar Duration and Content**: - The average duration of webinars remains around 52 minutes, suggesting that audiences are willing to stay engaged for longer periods if the content is valuable [11]. - The evolution of digital events has led to more interactive experiences, with HCPs seeking opportunities to participate and engage rather than just passively consume information [13][15]. 3. **Personalization and Segmentation**: - Personalization in digital experiences has become crucial, with a threefold increase in demo requests when experiences are tailored to specific audience segments [44]. - The ability to segment audiences based on various criteria (e.g., specialty, engagement level) allows for customized content delivery, enhancing engagement [34][40]. 4. **On-Demand Content**: - Life sciences companies have achieved a 51% split between live and on-demand content consumption, indicating a shift towards on-demand viewing [49]. - On-demand webinars drive higher engagement than live experiences, with audiences actively participating by asking questions and downloading content [52][56]. 5. **Content Hubs**: - The rise of content hubs has been noted, where companies create bingeable portals for HCPs to access a variety of resources and webinars [57][58]. - Content hub conversions have increased significantly, with an 85% growth in total meeting bookings from these hubs [63]. 6. **AI Integration**: - AI is being integrated into digital engagement platforms, enhancing the ability to create content from webinars, including automated transcripts and promotional materials [74][80]. - There has been a 10x increase in automated transcript requests and a 6x increase in AI-generated content pieces, indicating a growing reliance on AI for content creation [80]. Additional Important Points - The importance of first-party data is emphasized, as it helps marketers understand HCPs' needs and preferences, ultimately improving engagement strategies [19][90]. - The report highlights the need for continuous improvement in digital engagement strategies to adapt to changing audience behaviors and preferences [8][92]. - There is no evidence of "webinar fatigue"; rather, audiences are showing increased interest in well-structured and engaging webinars [104]. This comprehensive analysis of the ON24 briefing provides valuable insights into the evolving landscape of digital engagement in the life sciences sector, highlighting the importance of interactivity, personalization, and the integration of technology to enhance audience engagement.

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) announces that it has granted an additional 633,589 restricted share units (“RSUs”) and 330,132 stock options (“Options”) to continuing employees and consultants of Rocket Doctor Inc., the Company’s wholly-owned subsidiary (see News Release dated April 10, 2025). The ...

Core Viewpoint - Encompass Health Corporation (EHC) is well-positioned for growth by providing high-quality, cost-effective integrated care, achieving a 28.8% increase year-to-date, significantly outperforming the industry average of 2.7% [1] Company Overview - Encompass Health has a market capitalization of $12 billion and operates as an integrated healthcare services company based in Birmingham, AL, with a network of 166 inpatient rehabilitation hospitals across 38 states and Puerto Rico [2] - The company's forward P/E ratio stands at 22.78X, higher than the industry average of 19.62X, reflecting growing investor confidence [2] Financial Performance and Estimates - The Zacks Consensus Estimate for EHC's 2025 earnings is $5.01 per share, indicating a 13.1% year-over-year increase, with eight upward estimate revisions in the past two months [4] - Revenue estimates for 2025 are pegged at $5.9 billion, suggesting a 9.5% year-over-year rise, with the company beating earnings estimates in the past four quarters with an average surprise of 12.3% [4] Growth Drivers - Revenue growth is driven by increased discharges and pricing, with total discharges rising 6.3% year-over-year in Q1 2025 and net patient revenue per discharge growing 3.9% year-over-year, surpassing estimates by 1.6% [5] - The company plans to continue investing in its clinical team and expand its hospital network, including seven new facilities with 340 beds and a 50-bed freestanding satellite hospital in 2025 [6] Financial Stability - EHC's financial stability is supported by a strong liquidity position, holding $95.8 million in cash and cash equivalents as of March 31, 2025, a 12.2% increase from the end of 2024 [7] - Operating cash flows increased by 17.9% year-over-year in 2024 and 20.9% in Q1 2025 [7] - The trailing 12-month return on invested capital is 9.7%, exceeding the industry average of 5.8% [8] Revenue and EPS Guidance - The company has increased its net operating revenue forecast to a range of $5.85 billion to $5.925 billion [8] - Adjusted EPS guidance has been raised to between $4.85 and $5.10 [10]

The market expects HealthEquity (HQY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on June 3, 2025, might help the stock move higher if these key numbers are bet ...

Group 1: Encompass Health (EHC) - Encompass Health is a provider of integrated healthcare services with a Zacks Rank 1 (Strong Buy) [1] - The Zacks Consensus Estimate for its current year earnings has increased by 4.4% over the last 60 days [1] - The company has a PEG ratio of 2.42, which is lower than the industry average of 2.53, and possesses a Growth Score of A [1] Group 2: Great Lakes Dredge & Dock (GLDD) - Great Lakes Dredge & Dock is the largest provider of dredging services in the US, maintaining and deepening shipping channels [2] - The Zacks Consensus Estimate for its current year earnings has increased by 34.8% over the last 60 days [2] - The company has a PEG ratio of 0.98, significantly lower than the industry average of 1.57, and possesses a Growth Score of A [2] Group 3: The ODP Corporation (ODP) - The ODP Corporation provides business services, products, and digital workplace technology solutions to various business sizes [3] - The Zacks Consensus Estimate for its current year earnings has increased by 18.4% over the last 60 days [3] - The company has a PEG ratio of 0.38, which is much lower than the industry average of 3.86, and possesses a Growth Score of B [3]